Advertisement
Screener

Ascendis Pharma A/S (ASND) Noncurrent Assets

2.8 / 5 stars · 68/120 Roast Me

Ascendis Pharma A/S Noncurrent Assets

Ascendis Pharma A/S (ASND) had Noncurrent Assets of EUR 193.59 million as of 2025-12-31, per its 20-F filed 2026-02-11.

Financial Statements › Notes

ifrs-full:NoncurrentAssets · last filed 2026-02-11

  • 2025-12-31: Noncurrent Assets 193.59M EUR.
  • 2025-09-30: Noncurrent Assets 136.97M EUR.
  • 2025-06-30: Noncurrent Assets 134.94M EUR.
  • 2025-03-31: Noncurrent Assets 139.95M EUR.
Period endNoncurrent Assets
2025-12-31193.59M EUR
20-F · filed 2026-02-11
2025-09-30136.97M EUR
6-K · filed 2025-11-12
2025-06-30134.94M EUR
6-K · filed 2025-08-07
2025-03-31139.95M EUR
6-K · filed 2025-05-01
2024-12-31118.63M EUR
20-F · filed 2026-02-11
2024-09-30120.04M EUR
6-K · filed 2024-11-14
2024-06-30130.98M EUR
6-K · filed 2024-09-03
2024-03-31138.39M EUR
6-K · filed 2024-05-02
2023-12-31122.87M EUR
20-F · filed 2025-02-12
2023-09-30140.29M EUR
6-K · filed 2023-11-07
2023-06-30146.15M EUR
6-K · filed 2023-09-05
2023-03-31156.43M EUR
6-K · filed 2023-04-27
2023-01-01166.27M EUR
20-F · filed 2025-02-12
2022-12-31166.27M EUR
20-F · filed 2024-02-07
2022-09-30193.52M EUR
6-K · filed 2022-11-02
2022-06-30214.74M EUR
6-K · filed 2022-08-10
2022-03-31256.17M EUR
6-K · filed 2022-05-11
2021-12-31279.04M EUR
20-F · filed 2023-02-16
2021-09-30248.65M EUR
6-K · filed 2021-11-10
2021-06-30267.60M EUR
6-K · filed 2021-08-27
2021-03-31278.04M EUR
6-K · filed 2021-05-27
2020-12-31239.66M EUR
20-F · filed 2022-03-02
2020-09-3092.52M EUR
6-K · filed 2020-11-12
2020-06-3068.98M EUR
6-K · filed 2020-08-27
2020-03-3169.83M EUR
6-K · filed 2020-05-19
2019-12-3165.56M EUR
20-F · filed 2021-03-10
2019-09-3065.31M EUR
6-K · filed 2019-11-18
2019-06-3064.33M EUR
6-K · filed 2019-08-28
2019-03-3146.16M EUR
6-K · filed 2019-05-30
2018-12-3126.06M EUR
20-F · filed 2020-04-03
2018-09-308.25M EUR
6-K · filed 2018-11-28
2018-06-307.21M EUR
6-K · filed 2018-08-29
2018-03-317.07M EUR
6-K · filed 2018-05-30
2017-12-316.34M EUR
20-F · filed 2019-04-03
2016-12-316.11M EUR
20-F · filed 2018-03-28